Xiaohan Zhang

Prof. Xiaohan Zhang

Zhejiang University City College, Hangzhou, Zhejiang, China
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Chao WangChao Wang
Chao Wang
JZJieyu Zhang
Jieyu Zhang
Nicholas LassiNicholas Lassi
Nicholas Lassi
Xiaohan ZhangXiaohan Zhang
Xiaohan Zhang
Advanced artificial intelligence (AI) technologies are now widely employed in China’s medical and healthcare fields. Enormous amounts of personal data are collected from various sources and inserted into AI algorithms for medical purposes, producing challenges to patient’s privacy. This is a comparative study of Chinese, United States, and European Union operational rules for healthcare data that is collected and then used in AI functions, particularly focusing on legal differences and deficiencies. The conceptual boundaries of privacy and personal information, the influence of technological development on the informed consent model, and conflicts between freedom and security in rules of cross-border data flow were found to be key issues requiring consideration when regulating healthcare data used for AI purposes. Furthermore, the results indicate that the appropriate balance between privacy protections and technological development, between individual and group interests, and between corporate profits and the public interest should be identified and observed. In terms of specific rule-making, it was found that China should establish special regulations protecting healthcare information, provide clear definitions and classification schemas for different types of healthcare information, and enact stricter accountability mechanisms. Examining and contrasting operational rules for AI in health care promotes informed privacy governance and improved privacy legislation.

Verified
Journal Article
Open access
PDF file
Abdul MajeedAbdul Majeed
Abdul Majeed
Xiaohan ZhangXiaohan Zhang
Xiaohan Zhang
Seong Oun HwangSeong Oun Hwang
Seong Oun Hwang
Federated learning (FL) is one of the leading paradigms of modern times with higher privacy guarantees than any other digital solution. Since its inception in 2016, FL has been rigorously investigated from multiple perspectives. Some of these perspectives are extensions of FL’s applications in different sectors, communication overheads, statistical heterogeneity problems, client dropout issues, the legitimacy of FL system results, privacy preservation, etc. Recently, FL is being increasingly used in the medical domain for multiple purposes, and many successful applications exist that are serving mankind in various ways. In this work, we describe the novel applications and challenges of the FL paradigm with special emphasis on the COVID-19 pandemic. We describe the synergies of FL with other emerging technologies to accomplish multiple services to fight the COVID-19 pandemic. We analyze the recent open-source development of FL which can help in designing scalable and reliable FL models. Lastly, we suggest valuable recommendations to enhance the technical persuasiveness of the FL paradigm. To the best of the authors’ knowledge, this is the first work that highlights the efficacy of FL in the era of COVID-19. The analysis enclosed in this article can pave the way for understanding the technical efficacy of FL in medical field, specifically COVID-19.

5 August 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Xiaohan ZhangXiaohan Zhang
Xiaohan Zhang
Heath code apps, along with robust testing, isolation, and the care of cases, are a vital strategy for containing the spread of the COVID-19 outbreak in China. They have remained stable and consistent, allowing China to extensively restore its social and economic development. However, the ethical and legal boundaries of deploying health code apps for disease surveillance and control purposes are unclear, and a rapidly evolving debate has emerged around the promises and risks of their fast promotion. The article outlines the legal challenges by applying the core values of the Personal Information Protection Law (PIPL), the fundamental law for personal information protection in China, into the context of the nationwide use of health code apps. It elaborates on the balance between the demands for upholding individuals’ rights to the security of their personal information and those for public access to such information to prevent the spread of infectious diseases. It identifies the current gaps in addressing personal information harms during the use of the apps, particularly with regard to user consent, transparency, necessity, storage duration, and security safeguards.

Chao WangChao Wang
Chao Wang
Nicholas LassiNicholas Lassi
Nicholas Lassi
Xiaohan ZhangXiaohan Zhang
Xiaohan Zhang
Vinay SharmaVinay Sharma
Vinay Sharma
The rise of the synthetic opioid epidemic has time and time again brought criticism on China and India, the world’s two main producers of fentanyl and its chemical precursors. In the past few years, the two countries have attempted to strengthen regulations over fentanyl production and distribution, though its effects on global drug governance remain under scrutiny. This study used qualitative and comparative methods to investigate the current regulatory landscape for fentanyl, including its efficiency and potential loopholes in China and India. It concludes that although both China and India are actively and significantly attempting to step away from the global fentanyl supply chain, these efforts remain ineffective due to institutional loopholes, namely inadequate legislation and fragmented regulatory structures. From insights gained on global drug governance, we recommend a binding international convention concentrated on controlling fentanyl and its related substances, with further bilateral and multilateral cooperation among states as necessary complementation.

16 January 2023 in COVID
Verified
Journal Article
Open access
PDF file
Abdul MajeedAbdul Majeed
Abdul Majeed
Xiaohan ZhangXiaohan Zhang
Xiaohan Zhang
In the ongoing COVID-19 pandemic, digital technologies have played a vital role to minimize the spread of COVID-19, and to control its pitfalls for the general public. Without such technologies, bringing the pandemic under control would have been tricky and slow. Consequently, exploration of pandemic status, and devising appropriate mitigation strategies would also be difficult. In this paper, we present a comprehensive analysis of community-beneficial digital technologies that were employed to fight the COVID-19 pandemic. Specifically, we demonstrate the practical applications of ten major digital technologies that have effectively served mankind in different ways during the pandemic crisis. We have chosen these technologies based on their technical significance and large-scale adoption in the COVID-19 arena. The selected technologies are the Internet of Things (IoT), artificial intelligence(AI), natural language processing(NLP), computer vision (CV), blockchain (BC), federated learning (FL), robotics, tiny machine learning (TinyML), edge computing (EC), and synthetic data (SD). For each technology, we demonstrate the working mechanism, technical applications in the context of COVID-19, and major challenges from the perspective of COVID-19. Our analysis can pave the way to understanding the roles of these digital COVID-19-fighting technologies that can be used to fight future infectious diseases to prevent global crises. Moreover, we discuss heterogeneous data that have significantly contributed to addressing multiple aspects of the ongoing pandemic when fed to the aforementioned technologies. To the best of the authors’ knowledge, this is a pioneering work on community-beneficial and transformative technologies in the context of COVID-19 with broader coverage of studies and applications.

4 March 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
Xiaohan ZhangXiaohan Zhang
Xiaohan Zhang
Chao WangChao Wang
Chao Wang
During the COVID-19 pandemic in 2020, a number of international cruise ships were infected, thereby resulting in serious public health and human rights problems. Multiple difficulties were encountered in the prevention and control of the coronavirus disease onboard ships, while rule-based international cooperation in this regard appeared inefficient and ineffective. By applying interdisciplinary methodologies, including empirical research of law, policy science, and health studies, this research reviewed the legal difficulties in the prevention and control of COVID-19 on international cruise ships and sought solutions from a policy-making and strategic perspective. We found that, apart from the inherent nature of cruise ships such as crowded semi-enclosed areas, shared sanitary facilities and limited medical resources, there are also nonnegligible legal reasons affecting the effectiveness of containment measures on board. In particular, there is ambiguity and even inconsistency of relevant international norms and domestic regulations, and some of the key rules are neither mandatory nor enforceable. We conclude by suggesting that rule-based international cooperation on this issue must be strengthened with respect to information sharing and management, a more effective supervisory mechanism, clarification of key rules over jurisdiction and distributions of obligations among the port states, flag states, nationality states, and cruise ship companies.